Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study-Reference-Cited by-同舟云学术

Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study

Published:2018-12 Issue:12 Volume:2 Page:855-862
ISSN:2352-4642
Container-title:The Lancet Child & Adolescent Health
language:en
Short-container-title:The Lancet Child & Adolescent Health

Author:

Miyata Koichi,Kaneko Tetsuji,Morikawa Yoshihiko,Sakakibara Hiroshi,Matsushima Takahiro,Misawa Masahiro,Takahashi Tsutomu,Nakazawa Maki,Tamame Takuya,Tsuchihashi Takatoshi,Yamashita Yukio,Obonai Toshimasa,Chiga Michiko,Hori Naoaki,Komiyama Osamu,Yamagishi Hiroyuki,Miura Masaru

Publisher

Elsevier BV

Subject

Developmental and Educational Psychology,Pediatrics, Perinatology, and Child Health

Reference23 articles.

1. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version;Circ J,2014

2. Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version);Pediatr Int,2014

3. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association;McCrindle;Circulation,2017

4. Kawasaki disease: effect of treatment on coronary artery involvement;Kato;Pediatrics,1979

5. Coronary artery lesions and the increasing incidence of Kawasaki disease resistant to initial immunoglobulin;Kibata;Int J Cardiol,2016

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylprednisolone pulse and prednisolone for intensification of primary treatment in Kawasaki disease patients at high risk of treatment resistance: a multicenter prospective cohort study;European Journal of Pediatrics;2024-07-25

2. Treatment intensification in Kawasaki disease – current perspectives;Expert Review of Clinical Immunology;2024-07-15

3. Prediction Models for Intravenous Immunoglobulin Non-Responders of Kawasaki Disease Using Machine Learning;Clinical Drug Investigation;2024-06

4. Efficacy and safety of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis;European Journal of Pediatrics;2024-01-19

5. Jaundice-predominant manifestation of Kawasaki disease in children;Frontiers in Pediatrics;2024-01-09